FDA reform national uniformity wording may "eliminate" liability suits -- Public Citizen.
This article was originally published in The Tan Sheet
Executive Summary
FDA REFORM NATIONAL UNIFORMITY PROVISIONS COULD "ELIMINATE" PRODUCT LIABILITY lawsuits, Public Citizen asserted at a June 3 press conference in Washington, D.C. Public Citizen President Joan Claybrook took issue with a provision in the legislation establishing national uniformity for OTC drugs. The provision is included in both the House and Senate versions of FDA reform legislation ("The Tan Sheet" April 1, p. 1).